Literature DB >> 22166948

8q23.3 and 11q23.1 as modifying loci influencing the risk for CRC in Lynch syndrome.

Bente A Talseth-Palmer, Rodney J Scott, Hans F A Vasen, Juul T Wijnen.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22166948      PMCID： PMC3330213          DOI： 10.1038/ejhg.2011.232

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  3 in total

1.  Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome.

Authors:  Bente A Talseth-Palmer; Ingvild S Brenne; Katie A Ashton; Tiffany-Jane Evans; Mary McPhillips; Claire Groombridge; Janina Suchy; Grzegorz Kurzawski; Allan Spigelman; Jan Lubinski; Rodney J Scott
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

2.  Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.

Authors:  Juul T Wijnen; Richard M Brohet; Ronald van Eijk; Shanty Jagmohan-Changur; Anneke Middeldorp; Carli M Tops; Mario van Puijenbroek; Margreet G E M Ausems; Encarna Gómez García; Frederik J Hes; Nicoline Hoogerbrugge; Fred H Menko; Theo A M van Os; Rolf H Sijmons; Senno Verhoef; Anja Wagner; Fokko M Nagengast; Jan H Kleibeuker; Peter Devilee; Hans Morreau; David Goldgar; Ian P Tomlinson; Richard S Houlston; Tom van Wezel; Hans F A Vasen
Journal:  Gastroenterology       Date:  2008-09-25       Impact factor: 22.682

3.  Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers.

Authors:  Solene Houlle; Françoise Charbonnier; Estelle Houivet; Julie Tinat; Marie-Pierre Buisine; Olivier Caron; Jacques Benichou; Stéphanie Baert-Desurmont; Thierry Frebourg
Journal:  Eur J Hum Genet       Date:  2011-03-16       Impact factor: 4.246
  3 in total
  4 in total

1.  SCRIB and PUF60 are primary drivers of the multisystemic phenotypes of the 8q24.3 copy-number variant.

Authors:  Andrew Dauber; Christelle Golzio; Cécile Guenot; Francine M Jodelka; Maria Kibaek; Susanne Kjaergaard; Bruno Leheup; Danielle Martinet; Malgorzata J M Nowaczyk; Jill A Rosenfeld; Susan Zeesman; Janice Zunich; Jacques S Beckmann; Joel N Hirschhorn; Michelle L Hastings; Sebastien Jacquemont; Nicholas Katsanis
Journal:  Am J Hum Genet       Date:  2013-10-17       Impact factor: 11.025

2.  Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.

Authors:  Hans F A Vasen; Ignacio Blanco; Katja Aktan-Collan; Jessica P Gopie; Angel Alonso; Stefan Aretz; Inge Bernstein; Lucio Bertario; John Burn; Gabriel Capella; Chrystelle Colas; Christoph Engel; Ian M Frayling; Maurizio Genuardi; Karl Heinimann; Frederik J Hes; Shirley V Hodgson; John A Karagiannis; Fiona Lalloo; Annika Lindblom; Jukka-Pekka Mecklin; Pal Møller; Torben Myrhoj; Fokko M Nagengast; Yann Parc; Maurizio Ponz de Leon; Laura Renkonen-Sinisalo; Julian R Sampson; Astrid Stormorken; Rolf H Sijmons; Sabine Tejpar; Huw J W Thomas; Nils Rahner; Juul T Wijnen; Heikki Juhani Järvinen; Gabriela Möslein
Journal:  Gut       Date:  2013-02-13       Impact factor: 23.059

Review 3.  Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome.

Authors:  Aung Ko Win; Mark Clendenning; William Crawford; Christophe Rosty; Susan G Preston; Melissa C Southey; Susan Parry; Graham G Giles; Finlay A Macrae; Ingrid M Winship; John A Baron; John L Hopper; Mark A Jenkins; Daniel D Buchanan
Journal:  Genes Cancer       Date:  2015-11

4.  Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers.

Authors:  Z Ghorbanoghli; M H Nieuwenhuis; J J Houwing-Duistermaat; S Jagmohan-Changur; F J Hes; C M Tops; A Wagner; C M Aalfs; S Verhoef; E B Gómez García; R H Sijmons; F H Menko; T G Letteboer; N Hoogerbrugge; T van Wezel; H F A Vasen; J T Wijnen
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.